Payden & Rygel Johnson & Johnson Transaction History

Payden & Rygel

$1.3 Billion
Q3 2024

A detailed history of Payden & Rygel transactions in Johnson & Johnson stock. As of the latest transaction made, Payden & Rygel holds 43,800 shares of JNJ stock, worth $6.3 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

43,800

Previous 43,800 -0.0%

Holding current value

$6.3 Million

Previous $6.4 Million 10.87%

% of portfolio

0.55%

Previous 0.52%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	SELL	$144.38 - $157.78 $4.98 Million - $5.44 Million	-34,500 Reduced 44.06%	43,800 $6.4 Million
Q1 2024 Oct 08, 2024	BUY	$155.22 - $162.74 $7.31 Million - $7.67 Million	47,100 Added 107.53%	90,900 $14.4 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $247,520 - $270,096	-1,700 Reduced 2.13%	78,300 $12.3 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $6.7 Million - $7.21 Million	-43,400 Reduced 35.17%	80,000 $13.2 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $815,670 - $973,404	5,400 Added 4.58%	123,400 $19.1 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $451,724 - $502,656	2,800 Added 2.43%	118,000 $19.3 Million
Q1 2022 Apr 13, 2022	SELL	$158.14 - $179.59 $8.71 Million - $9.9 Million	-55,100 Reduced 32.35%	115,200 $20.4 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $1.02 Million - $1.13 Million	6,300 Added 3.84%	170,300 $27.5 Million
Q2 2021 Aug 06, 2021	SELL	$159.48 - $171.07 $127,583 - $136,856	-800 Reduced 0.49%	164,000 $27 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $489,824 - $545,536	3,200 Added 1.98%	164,800 $27.1 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $6.37 Million - $6.98 Million	45,400 Added 39.07%	161,600 $24.1 Million
Q1 2020 May 04, 2020	BUY	$111.14 - $153.99 $766,866 - $1.06 Million	6,900 Added 6.31%	116,200 $15.2 Million
Q3 2019 Oct 30, 2019	SELL	$126.95 - $142.14 $10.6 Million - $11.8 Million	-83,300 Reduced 43.25%	109,300 $14.1 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $144,265 - $158,664	1,100 Added 0.57%	192,600 $26.8 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $12.5 Million - $13.9 Million	99,600 Added 108.38%	191,500 $26.8 Million
Q4 2018 Jan 25, 2019	BUY	$122.84 - $147.84 $10 Million - $12.1 Million	81,700 Added 800.98%	91,900 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $1.32 Million - $1.38 Million	10,200	10,200 $1.33 Million

Others Institutions Holding JNJ

# of Institutions

4,274

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $376B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.

Account